Paper
Document
Submit new version
Download
Flag content
0

Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment

0
TipTip
Save
Document
Submit new version
Download
Flag content